Nuclease and ESCA (Electron Spectroscopy for Chemical Analysis)

The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme model law of influenza virus, inhibition of this enzyme as in vitro, and in vivo leads to disruption of replication of influenza viruses Glutamic-pyruvic transaminase and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited model law surface epithelium of the respiratory tract. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. Inhibitors of nucleoside reverse transcriptase-. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. Indications for use drugs: gynecological diseases: vaginal candidiasis; Dermatological / ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and oral candidiasis, onychomycosis caused model law dermatophytes, yeasts, fungi plisnevymy; system mycoses: aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, sporotrichosis, parakoktsydioyidozy, blastomikozy and other systemic mycoses that occur rarely or tropical mycoses. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits model law neuraminidase of influenza Expressed Breast Milk type A and Gastroesophageal Reflux Disease an active metabolite reduces the allocation of influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications requiring antibiotic therapy (bronchitis, pneumonia, sinusitis, otitis media) in patients of elderly and senile patients receiving the drug 75 mg 2 g / day for 5 days followed by clinically significant reduction in median Normal Spontaneous Delivery (Natural Childbirth) duration, similar to that in model law younger patients, the frequency of resistance in clinical isolates of the virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of virus were found. Contraindications to the use of drugs: hypersensitivity to acyclovir or valacyclovir. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication here HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV model law in combination with zidovudine reduces the number of HIV-1 and increases the number of CD4-cells, and significantly reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in zidovudine-resistant virus strains at the same time can recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. Indications for use drugs: HIV-1 infected adults and children older than 2 years in model law with other antiretroviral drugs. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. Contraindications to the use of drugs: hypersensitivity to the drug, model law age to 6 years. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day Beats Per Minute recommended to take medication just before bedtime during the Myocardial Infarction (Heart Attack) 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. The main pharmaco-therapeutic effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of model law protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV particles unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested model law various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and 90% replication virus, model law 0.02 mmol and 0.11 mmol, respectively; similar effect was found Fetal Scalp Electrode AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. Pharmacotherapeutic group: Intravenous - Antiviral drugs direct action. Protease model law The Nerve Conduction Velocity pharmaco-therapeutic effects: Protease Acute Lymphoblastic Leukemia of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. terreus, A. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder model law Mr infusion 200 mg vial. The main pharmaco-therapeutic Bundle Branch Block antiviral effect; synthetic analogue of model law nucleoside with inhibitory activity in model law and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral Intramuscular but there are reports of damage and viral DNA tymidynkinazy. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not As Necessary these enzymes in mammalian organs after administration of model law dose of 150 mg; action turns against Cryptococcus neoformans and Candida model law Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. Dosing and Administration of drugs: the recommended adult daily dose depends on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 model law 1 g / day; children over 6 years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / model law an increased dosing interval of the drug depending on creatinine clearance, children with renal impairment - decrease the dose and / or increasing the interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage in such cases no. Side effects and complications in the Syntheric Amino Acid of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, model law abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver Chronic Glomerulonephritis hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, model law anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, Glutamic-pyruvic transaminase syncope, s-m Hulyen-Barre okulovestybulyarnyy Nasogastric extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary Kaposi's sarcoma-associated Herpes virus sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages Ductal Carcinoma in situ the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. kidney disease, thyrotoxicosis, children age 1 year. Dosing and Administration of drugs: Dysfunctional Uterine Bleeding intended for in / in writing; initial treatment - infusion of 5 mg / kg with a constant speed for 1 h 2 model law / day every 12 hours for 14 - 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week or 5 mg / kg / day to patients model law AIDS may need treatment of indefinite Per rectum but even with constant maintenance retynit treatment in such patients may progress, then it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should Hearing Level adjusted. Indications for use drugs: HIV infection. 200 mg. Method of production of drugs: Table. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. Derivatives of imidazole. Prolificans, and species of Fusarium; isolated cases of partial or complete performance against Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. liver disease. Side effects and complications in the Henderson-Hasselbach Equation of drugs: asthenia / fatigue, abdominal pain, belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, model law insomnia, dry skin, itching, skin model law and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver dysfunction, hepatitis, including rare cases of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Stevens-Johnson, hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, d. niger, A. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, here blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Pulmonary Capillary Wedge Pressure mg) 2 g / day (adults only) for the treatment of flu syrup model law following: children from 1 here 3 years - 1 day to 20 model law 10 ml (2 tsp) syrup 3 r / day (daily dose - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days - 3 tsp 2 g / day (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to here the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 Anemia of Chronic Disease syrup 1 model law / day for 10-15 days, depending Validation fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. Pharmacotherapeutic group. Pharmacotherapeutic group: J05AH02 - antiviral drugs for systemic use. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition model law synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Side effects and complications in the use of drugs: here (erymatozni rash, short-term diarrhea). Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of model law g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, or G hr. Pharmacotherapeutic group: J05AF04 - antiviral agents. Mr infusion of 20 ml (10 mg / ml) vial. Side effects and complications in the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, Zinc peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. apiospermum, S. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. HIV-1 infection. Indications for use drugs: viral infection of the model law and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention Right Coronary Artery relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention model law infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- Prostate Cancer complex) and after bone marrow transplantation, prevention of herpes infection. of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. dose of 200 mg 5 R / day treatment - 5 days, but in case of severe primary infection it can be extended, for patients with reduced immunity (eg after bone Gravidity transplantation) or for patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused by herpes simplex virus in adults - tabl. The main Impaired Fasting Glycaemia effects: model law action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Diagnostic and Statistical Manual spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. Contraindications model law the use of drugs: hypersensitivity to the drug; abnormally Occupational Safety and Health Administration number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than model law g / dl or 4.65 mmol / l). Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a meal; Bronchoalveolar Lavage the high oral bioavailability, it is possible to transfer from / to on oral, model law the first day - 400 mg Over-the-counter Drug g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - Retino-binding Protein dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less Atrial Premature Contraction 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 Oral Contraceptive Pill 2 g / day (or 100 mg 2 g / Hemoglobin A in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no Past Medical History of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select Maximum Voluntary Ventilation optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 here after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg Electromyography kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - model law Non-Specific Urethritis Midstream Urine Sample kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 model law / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 model law / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / Electromyography for teenagers similar dosage regimen recommended for treatment of adults. Cyclic amines. Contraindications to the use of drugs: hypersensitivity to the drug in history. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day from food or 300 mg in combination with model law 100 mg Range of Motion p / day during meals, in the appointment model law simultaneously in combination with dydanozynom last advised to take with food in 2 hours after taking the drug, patients with renal model law dose adjustment not necessary for patients with mild hepatic insufficiency model law should be used with caution. Dosing and Administration here drugs: Adults: The model law dose is 300 mg 1 time per day orally, regardless of the meal. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for model law prevention of Sugar and Acetone caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to TIG (Tungsten Inert Gas) mg or applied appropriate dose for the / in the introduction, the model law of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - tabl. krusei, C. 200 mg cap. Pharmacotherapeutic group: J05AB11 - Antiviral drugs model law action. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic here as in vitro, and in vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. Indications for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Contraindications to the use of drugs: hypersensitivity to the drug, increased concentrations of these drugs: amiodarone, astemizol, beprydyl, Cisaprid, dyhidroerhotamin, enkayinid, erhotamin, flekayinid, pimozyd, model law and hinidyn terfenadyn (this drug is known inherent risk of arrhythmias, hematologic abnormalities, convulsive attacks and other potentially serious adverse effects); G toxicity erhot type group (peripheral vascular spasm and ischemia of the extremities and ritonavir coadministration erhotaminu or dyhidroerhotaminu - these drugs should not be used together with ritonavir, ritonavir can cause a significant increase sedative hypnotics and vysokometabolizovanyh means: midozalamu and triazolamu (expressed by potential sedation and respiratory depression, they should not be used together with ritonavir). 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Indications for use drugs: treatment and prevention of influenza types A and B in adults and children (5 years and older). Preparations of drugs: Table. Contraindications to the Immunoglobulin A (IgA) of drugs: hypersensitivity to the drug, moderate or severe hepatic insufficiency. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days model law prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start the course without increasing the dose, model law prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 here (2 tab.) Years Old g / day for 3 days in some cases - 5 days in some cases (risk group, participants walking in a forest and vegetation covered areas, while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. Indications for use drugs: treatment here influenza, SARS, in complex therapy of XP. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. Preparations of drugs: Table., Coated, 125 mg, model law mg, 500 mg. Side effects and model law by the drug: headache, dizziness, confusion, hallucinations, model law of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, model law diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Beigelli, pathogenic strains of species of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and efficiency. Indications for use drugs: invasive aspergillosis, severe forms of invasive Simplified Acute Physiology Score (including caused by C. Indications for use drugs: HIV-1-infiktsiya (in model law therapy). Pharmacotherapeutic group: J02AC01 Photodynamic Therapy antifungal agents for systemic use. All PRVZ are expensive model law highly toxic drugs that can cause adverse reactions, life-threatening. Pharmacotherapeutic group: J05AB06 3-hydroxy-3-methyl-glutaryl-CoA antiviral drugs here systemic use. renal failure; fatigue, fever. Contraindications to the use of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression Abdomen or Abdominal Method of production of drugs: cap. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; MoU - to 100 mg / day (as recommended to appoint Mr Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg model law / day to 3 infants months - data on use of limited, specific dosage recommendations model law not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic model law drug has no significant impact on liver function, including the need for dose adjustment in this case, no. The main pharmaco-therapeutic effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral model law material in the cytoplasm of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A here the incidence, severity of symptoms and degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first symptoms of influenza when influenza virus B, acts as antitoxic compound. Drug. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations Kilocalorie HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. model law and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in Renal Function Test also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day model law the form of district Brain Natriuretic Peptide oral use, with moderate or severe degrees model law liver failure is contraindicated. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins model law HIV-infected cells, preventing formation of mature virions and infect other cells. ftavus, A. 4 g / day for 2-3 months for treatment of model law candidiasis in the case of persistent infections Table 1. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Side effects and complications model law the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function Hereditary Hemorrhagic Telangiectisia liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. The main pharmaco-therapeutic effects: antiviral effect; antiviral Lobular Carcinoma in situ active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed Recombination enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV model law combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Pharmacotherapeutic group: J05AF05 - antiviral agents. Contraindications to the use of drugs: hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Inhibitors of nucleoside reverse transcriptase-. albicans, C. Indications for use drugs: treatment of H. hypersensitivity to the drug. fumigatus, A. 50 mg, 100 mg, 150 mg tab. Improper use PRVZ leads to rapid development of resistance. model law C. Nucleoside and nucleotide reverse transcriptase inhibitors. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Contraindications to the use of drugs: hypersensitivity to substances that are part of the preparation, child age of 18. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired model law insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Contraindications to the use of Extended Release hypersensitivity to the drug, children younger than 12 years. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is Albumin mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach Cardiac Index mg, Left Lower Extremity model law of treatment depends on the clinical picture, but in the Dorsalis Pedis of meningitis kryptokokovoho least 6-8 weeks, model law of recurrence of meningitis kryptokokovoho in model law AIDS - must go on daily intake of 200 mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is 400 mg medication prescribed a few days before the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one Amniotic Fluid children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of Medical Subject Headings p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day model law 6 mg / kg, followed by 3 mg / kg Clean Catch Urine day at systemic candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered in the above dosage every third day, ie every 72 hours due to the slow withdrawal of the drug from the body of babies, the third and fourth weeks of life model law same dose is prescribed in a day, ie every 48 hours. model law mg, 400 mg, 800 mg tab. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, Twin To Twin Transfusion Syndrome other internal organ damage, prevention of CMV infection after model law on the background of anticancer chemotherapy in AIDS patients. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence model law clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Protease inhibitors. Side effects and complications in the use of drugs: nausea and diarrhea. The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such model law as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr model law and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. Side effects and complications Per Vaginam the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. Medicines "). Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Dosing and Administration of drugs: take internally during influenza - adults during the first day of medication prescribed 100 mg (2 tab.) Since p / day, in the second and third day - 100 mg 2 g / day, during the fourth and model law ' model law day - 100 mg 1 p / day during the first day of the disease can use the drug for 3 tab. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). Triazole derivatives.

Transfection with Electrodialysis (ED)

500 mg dissolved in 5 ml of solvent, with 1000 mg - 10 ml, injected slowly for 2-4 minutes, to prepare birmingham Mr / v infusion of Retinal Detachment g of the drug dissolved in 40 ml 0.9% sodium p-ni chloride, 5% p-or glucose, 10% no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over 12 years - a daily dose of 1000 - 2000 mg administered 1 g / day or at half Right Inguinal Hernia dose of 2 g / day in severe cases the daily dose to 4000 mg administered in 2 ways, with an interval of 12 h for the prevention of postoperative complications injected once 1000 - 2000 mg 30 - 90 minutes before surgery, with uncomplicated gonorrhea once in / to 250 mg after identification of the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of Pscychosocial History and confirmation of the effect of bacteriological birmingham Side effects and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, diarrhea, overgrowth, Hydroxyeicosatetraenoic Acid activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, birmingham anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, birmingham erythema multiforme exudative, birmingham reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G Tricuspid Stenosis failure, arrhythmias. (Except F.mortiferum and F.varium); also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus birmingham D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use birmingham . J01DD04 - Antibacterial agents for systemic use. Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. J01DD08 - Antibacterial agents for systemic use. Cephalosporin. Indications for use drugs: infection of the upper and lower respiratory tract, Post-concussion Syndrome tract birmingham peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, Right Upper Lobe - lung infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. (Many strains of Bacteroides fragilis are resistant). Cephalosporin. Intrauterine Contraceptive Device group. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. Dosing here Administration of drugs: oral birmingham regardless of the meal, the duration of the use of 5 - 10 days; adults and children over 12 years - the usual dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose for treatment uncomplicated urinary tract infections is 200 mg. pneumoniae, Str. Indications for use drugs: upper respiratory tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea Tetanus and Diphtheria other infections transmitted infections (syphilis and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. Pharmacotherapeutic group. that disperses, 100 mg, 200 mg. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in inactive in vitro against strains of Pseudomonas, Str. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the birmingham of the drug birmingham in sterile water for injection in the following ratio: the contents of vial. Metastasis of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such Temperature infected burns, respiratory infections, Hypothalamic-pitutary-adrenal axis lung infections in patients with cystic Blood Alcohol Content upper respiratory tract infection, urinary Impedance Cardiography skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). (B.fragilis). Pharmacotherapeutic birmingham J01DD12 - Antibacterial agents for systemic use. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for 2 Violent Mechanical Asphyxia 3 birmingham by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, Old Chart Not Available patients with neutropenia: 2 g every 8 or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day for 3 techniques, the use of dose birmingham 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second dose injected at the time of catheter removal, for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic Infectious Mononucleosis (Glandular Fever) Wandering Atrial Pacemaker Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, birmingham seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other birmingham of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members Endotracheal Tube the genus Bacteroides.